retatrutide injection site reaction Tirzepatide-Induced Peptide Injection Site Reactions: What's

It mimics the hormone GLP-1, which helps regulate blood sugar and appetite

Abdomen The abdomen is the most common GLP-1 injection site

For Healthcare Professionals (HCPs) Tailored approaches to GLP-1 RA treatment plans are needed to ensure sustainable weight loss strategies, improve patient adherence, and support healthier dietary intakes

Individuals with a history of pancreatitis or severe gastrointestinal diseases should consult their provider for alternative solutions

Liraglutide (Saxenda) Liraglutide was the first GLP-1 drug approved specifically for weight management in Australia

Fascinatingly, exendin-4 appears to stimulate cholangiocyte proliferation through the GLP-1 receptor, hereby preventing cholangiocyte apoptosis in models of bile acid-induced damage and models of ductopenic cholangiopathies (95, 96)